3.25.4 html 449 654 1 false 147 0 false 17 false false R1.htm 0000001 - Document - Cover Sheet http://www.anipharmaceuticals.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://www.anipharmaceuticals.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 9952151 - Statement - Consolidated Balance Sheets Sheet http://www.anipharmaceuticals.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 3 false false R4.htm 9952152 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.anipharmaceuticals.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 4 false false R5.htm 9952153 - Statement - Consolidated Statements of Operations Sheet http://www.anipharmaceuticals.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 5 false false R6.htm 9952154 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.anipharmaceuticals.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) Statements 6 false false R7.htm 9952155 - Statement - Consolidated Statements of Changes in Mezzanine Equity and Stockholders' Equity Sheet http://www.anipharmaceuticals.com/role/ConsolidatedStatementsofChangesinMezzanineEquityandStockholdersEquity Consolidated Statements of Changes in Mezzanine Equity and Stockholders' Equity Statements 7 false false R8.htm 9952156 - Statement - Consolidated Statements of Cash Flows Sheet http://www.anipharmaceuticals.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 9952157 - Disclosure - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.anipharmaceuticals.com/role/DESCRIPTIONOFBUSINESSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 9952158 - Disclosure - REVENUE RECOGNITION AND RELATED ALLOWANCES Sheet http://www.anipharmaceuticals.com/role/REVENUERECOGNITIONANDRELATEDALLOWANCES REVENUE RECOGNITION AND RELATED ALLOWANCES Notes 10 false false R11.htm 9952159 - Disclosure - BUSINESS COMBINATION Sheet http://www.anipharmaceuticals.com/role/BUSINESSCOMBINATION BUSINESS COMBINATION Notes 11 false false R12.htm 9952160 - Disclosure - RESTRUCTURING CANADA OPERATIONS Sheet http://www.anipharmaceuticals.com/role/RESTRUCTURINGCANADAOPERATIONS RESTRUCTURING CANADA OPERATIONS Notes 12 false false R13.htm 9952161 - Disclosure - 2021 CREDIT FACILITY Sheet http://www.anipharmaceuticals.com/role/A2021CREDITFACILITY 2021 CREDIT FACILITY Notes 13 false false R14.htm 9952162 - Disclosure - 2024 CREDIT AGREEMENT Sheet http://www.anipharmaceuticals.com/role/A2024CREDITAGREEMENT 2024 CREDIT AGREEMENT Notes 14 false false R15.htm 9952163 - Disclosure - 2.25% CONVERTIBLE SENIOR NOTES Notes http://www.anipharmaceuticals.com/role/A225CONVERTIBLESENIORNOTES 2.25% CONVERTIBLE SENIOR NOTES Notes 15 false false R16.htm 9952164 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENT AND HEDGING ACTIVITY Sheet http://www.anipharmaceuticals.com/role/DERIVATIVEFINANCIALINSTRUMENTANDHEDGINGACTIVITY DERIVATIVE FINANCIAL INSTRUMENT AND HEDGING ACTIVITY Notes 16 false false R17.htm 9952165 - Disclosure - INVENTORIES Sheet http://www.anipharmaceuticals.com/role/INVENTORIES INVENTORIES Notes 17 false false R18.htm 9952166 - Disclosure - PROPERTY AND EQUIPMENT, NET Sheet http://www.anipharmaceuticals.com/role/PROPERTYANDEQUIPMENTNET PROPERTY AND EQUIPMENT, NET Notes 18 false false R19.htm 9952167 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Sheet http://www.anipharmaceuticals.com/role/GOODWILLANDINTANGIBLEASSETS GOODWILL AND INTANGIBLE ASSETS Notes 19 false false R20.htm 9952168 - Disclosure - FAIR VALUE Sheet http://www.anipharmaceuticals.com/role/FAIRVALUE FAIR VALUE Notes 20 false false R21.htm 9952169 - Disclosure - MEZZANINE AND STOCKHOLDERS' EQUITY Sheet http://www.anipharmaceuticals.com/role/MEZZANINEANDSTOCKHOLDERSEQUITY MEZZANINE AND STOCKHOLDERS' EQUITY Notes 21 false false R22.htm 9952170 - Disclosure - EARNINGS (LOSS) PER SHARE Sheet http://www.anipharmaceuticals.com/role/EARNINGSLOSSPERSHARE EARNINGS (LOSS) PER SHARE Notes 22 false false R23.htm 9952171 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.anipharmaceuticals.com/role/STOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 23 false false R24.htm 9952172 - Disclosure - INCOME TAXES Sheet http://www.anipharmaceuticals.com/role/INCOMETAXES INCOME TAXES Notes 24 false false R25.htm 9952173 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.anipharmaceuticals.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 25 false false R26.htm 9952174 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.anipharmaceuticals.com/role/RELATEDPARTYTRANSACTIONS RELATED PARTY TRANSACTIONS Notes 26 false false R27.htm 9952175 - Disclosure - SEGMENT REPORTING Sheet http://www.anipharmaceuticals.com/role/SEGMENTREPORTING SEGMENT REPORTING Notes 27 false false R28.htm 9952176 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.anipharmaceuticals.com/role/SUBSEQUENTEVENTS SUBSEQUENT EVENTS Notes 28 false false R29.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 29 false false R30.htm 995447 - Disclosure - Insider Trading Policies and Procedures Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc Insider Trading Policies and Procedures Notes 30 false false R31.htm 995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure Sheet http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure Cybersecurity Risk Management and Strategy Disclosure Notes 31 false false R32.htm 9955511 - Disclosure - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.anipharmaceuticals.com/role/DESCRIPTIONOFBUSINESSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 32 false false R33.htm 9955512 - Disclosure - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.anipharmaceuticals.com/role/DESCRIPTIONOFBUSINESSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.anipharmaceuticals.com/role/DESCRIPTIONOFBUSINESSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 33 false false R34.htm 9955513 - Disclosure - REVENUE RECOGNITION AND RELATED ALLOWANCES (Tables) Sheet http://www.anipharmaceuticals.com/role/REVENUERECOGNITIONANDRELATEDALLOWANCESTables REVENUE RECOGNITION AND RELATED ALLOWANCES (Tables) Tables http://www.anipharmaceuticals.com/role/REVENUERECOGNITIONANDRELATEDALLOWANCES 34 false false R35.htm 9955514 - Disclosure - BUSINESS COMBINATION (Tables) Sheet http://www.anipharmaceuticals.com/role/BUSINESSCOMBINATIONTables BUSINESS COMBINATION (Tables) Tables http://www.anipharmaceuticals.com/role/BUSINESSCOMBINATION 35 false false R36.htm 9955515 - Disclosure - 2021 CREDIT FACILITY (Tables) Sheet http://www.anipharmaceuticals.com/role/A2021CREDITFACILITYTables 2021 CREDIT FACILITY (Tables) Tables http://www.anipharmaceuticals.com/role/A2021CREDITFACILITY 36 false false R37.htm 9955516 - Disclosure - 2024 CREDIT AGREEMENT (Tables) Sheet http://www.anipharmaceuticals.com/role/A2024CREDITAGREEMENTTables 2024 CREDIT AGREEMENT (Tables) Tables http://www.anipharmaceuticals.com/role/A2024CREDITAGREEMENT 37 false false R38.htm 9955517 - Disclosure - INVENTORIES (Tables) Sheet http://www.anipharmaceuticals.com/role/INVENTORIESTables INVENTORIES (Tables) Tables http://www.anipharmaceuticals.com/role/INVENTORIES 38 false false R39.htm 9955518 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) Sheet http://www.anipharmaceuticals.com/role/PROPERTYANDEQUIPMENTNETTables PROPERTY AND EQUIPMENT, NET (Tables) Tables http://www.anipharmaceuticals.com/role/PROPERTYANDEQUIPMENTNET 39 false false R40.htm 9955519 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) Sheet http://www.anipharmaceuticals.com/role/GOODWILLANDINTANGIBLEASSETSTables GOODWILL AND INTANGIBLE ASSETS (Tables) Tables http://www.anipharmaceuticals.com/role/GOODWILLANDINTANGIBLEASSETS 40 false false R41.htm 9955520 - Disclosure - FAIR VALUE (Tables) Sheet http://www.anipharmaceuticals.com/role/FAIRVALUETables FAIR VALUE (Tables) Tables http://www.anipharmaceuticals.com/role/FAIRVALUE 41 false false R42.htm 9955521 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables) Sheet http://www.anipharmaceuticals.com/role/EARNINGSLOSSPERSHARETables EARNINGS (LOSS) PER SHARE (Tables) Tables http://www.anipharmaceuticals.com/role/EARNINGSLOSSPERSHARE 42 false false R43.htm 9955522 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.anipharmaceuticals.com/role/STOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION (Tables) Tables http://www.anipharmaceuticals.com/role/STOCKBASEDCOMPENSATION 43 false false R44.htm 9955523 - Disclosure - INCOME TAXES (Tables) Sheet http://www.anipharmaceuticals.com/role/INCOMETAXESTables INCOME TAXES (Tables) Tables http://www.anipharmaceuticals.com/role/INCOMETAXES 44 false false R45.htm 9955524 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://www.anipharmaceuticals.com/role/COMMITMENTSANDCONTINGENCIESTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://www.anipharmaceuticals.com/role/COMMITMENTSANDCONTINGENCIES 45 false false R46.htm 9955525 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) Sheet http://www.anipharmaceuticals.com/role/RELATEDPARTYTRANSACTIONSTables RELATED PARTY TRANSACTIONS (Tables) Tables http://www.anipharmaceuticals.com/role/RELATEDPARTYTRANSACTIONS 46 false false R47.htm 9955526 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://www.anipharmaceuticals.com/role/SEGMENTREPORTINGTables SEGMENT REPORTING (Tables) Tables http://www.anipharmaceuticals.com/role/SEGMENTREPORTING 47 false false R48.htm 9955527 - Disclosure - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Sheet http://www.anipharmaceuticals.com/role/DESCRIPTIONOFBUSINESSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Details http://www.anipharmaceuticals.com/role/DESCRIPTIONOFBUSINESSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 48 false false R49.htm 9955528 - Disclosure - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - PPE and Intangibles (Details) Sheet http://www.anipharmaceuticals.com/role/DESCRIPTIONOFBUSINESSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPPEandIntangiblesDetails DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - PPE and Intangibles (Details) Details 49 false false R50.htm 9955529 - Disclosure - REVENUE RECOGNITION AND RELATED ALLOWANCES - Disaggregation (Details) Sheet http://www.anipharmaceuticals.com/role/REVENUERECOGNITIONANDRELATEDALLOWANCESDisaggregationDetails REVENUE RECOGNITION AND RELATED ALLOWANCES - Disaggregation (Details) Details 50 false false R51.htm 9955530 - Disclosure - REVENUE RECOGNITION AND RELATED ALLOWANCES - Timing (Details) Sheet http://www.anipharmaceuticals.com/role/REVENUERECOGNITIONANDRELATEDALLOWANCESTimingDetails REVENUE RECOGNITION AND RELATED ALLOWANCES - Timing (Details) Details http://www.anipharmaceuticals.com/role/REVENUERECOGNITIONANDRELATEDALLOWANCESTables 51 false false R52.htm 9955531 - Disclosure - REVENUE RECOGNITION AND RELATED ALLOWANCES - Allowances (Details) Sheet http://www.anipharmaceuticals.com/role/REVENUERECOGNITIONANDRELATEDALLOWANCESAllowancesDetails REVENUE RECOGNITION AND RELATED ALLOWANCES - Allowances (Details) Details 52 false false R53.htm 9955532 - Disclosure - REVENUE RECOGNITION AND RELATED ALLOWANCES - Concentration (Details) Sheet http://www.anipharmaceuticals.com/role/REVENUERECOGNITIONANDRELATEDALLOWANCESConcentrationDetails REVENUE RECOGNITION AND RELATED ALLOWANCES - Concentration (Details) Details 53 false false R54.htm 9955533 - Disclosure - BUSINESS COMBINATION - Narrative (Details) Sheet http://www.anipharmaceuticals.com/role/BUSINESSCOMBINATIONNarrativeDetails BUSINESS COMBINATION - Narrative (Details) Details 54 false false R55.htm 9955534 - Disclosure - BUSINESS COMBINATION - Business acquisitions, by acquisition (Details) Sheet http://www.anipharmaceuticals.com/role/BUSINESSCOMBINATIONBusinessacquisitionsbyacquisitionDetails BUSINESS COMBINATION - Business acquisitions, by acquisition (Details) Details 55 false false R56.htm 9955535 - Disclosure - BUSINESS COMBINATION - Recognized identified assets acquired and liabilities assumed (Details) Sheet http://www.anipharmaceuticals.com/role/BUSINESSCOMBINATIONRecognizedidentifiedassetsacquiredandliabilitiesassumedDetails BUSINESS COMBINATION - Recognized identified assets acquired and liabilities assumed (Details) Details 56 false false R57.htm 9955536 - Disclosure - BUSINESS COMBINATION - Finite-lived intangible assets acquired as part of business combination (Details) Sheet http://www.anipharmaceuticals.com/role/BUSINESSCOMBINATIONFinitelivedintangibleassetsacquiredaspartofbusinesscombinationDetails BUSINESS COMBINATION - Finite-lived intangible assets acquired as part of business combination (Details) Details 57 false false R58.htm 9955537 - Disclosure - BUSINESS COMBINATION - Pro-forma activity (Details) Sheet http://www.anipharmaceuticals.com/role/BUSINESSCOMBINATIONProformaactivityDetails BUSINESS COMBINATION - Pro-forma activity (Details) Details 58 false false R59.htm 9955538 - Disclosure - RESTRUCTURING CANADA OPERATIONS (Details) Sheet http://www.anipharmaceuticals.com/role/RESTRUCTURINGCANADAOPERATIONSDetails RESTRUCTURING CANADA OPERATIONS (Details) Details http://www.anipharmaceuticals.com/role/RESTRUCTURINGCANADAOPERATIONS 59 false false R60.htm 9955539 - Disclosure - 2021 CREDIT FACILITY - Credit facility (Details) Sheet http://www.anipharmaceuticals.com/role/A2021CREDITFACILITYCreditfacilityDetails 2021 CREDIT FACILITY - Credit facility (Details) Details 60 false false R61.htm 9955540 - Disclosure - 2021 CREDIT FACILITY - Interest (Details) Sheet http://www.anipharmaceuticals.com/role/A2021CREDITFACILITYInterestDetails 2021 CREDIT FACILITY - Interest (Details) Details 61 false false R62.htm 9955541 - Disclosure - 2024 CREDIT AGREEMENT - Narrative (Details) Sheet http://www.anipharmaceuticals.com/role/A2024CREDITAGREEMENTNarrativeDetails 2024 CREDIT AGREEMENT - Narrative (Details) Details 62 false false R63.htm 9955542 - Disclosure - 2024 CREDIT AGREEMENT - Facility components (Details) Sheet http://www.anipharmaceuticals.com/role/A2024CREDITAGREEMENTFacilitycomponentsDetails 2024 CREDIT AGREEMENT - Facility components (Details) Details 63 false false R64.htm 9955543 - Disclosure - 2024 CREDIT AGREEMENT - Maturity of credit facility (Details) Sheet http://www.anipharmaceuticals.com/role/A2024CREDITAGREEMENTMaturityofcreditfacilityDetails 2024 CREDIT AGREEMENT - Maturity of credit facility (Details) Details 64 false false R65.htm 9955544 - Disclosure - 2024 CREDIT AGREEMENT - Interest (Details) Sheet http://www.anipharmaceuticals.com/role/A2024CREDITAGREEMENTInterestDetails 2024 CREDIT AGREEMENT - Interest (Details) Details 65 false false R66.htm 9955545 - Disclosure - 2.25% CONVERTIBLE SENIOR NOTES - Narrative (Details) Notes http://www.anipharmaceuticals.com/role/A225CONVERTIBLESENIORNOTESNarrativeDetails 2.25% CONVERTIBLE SENIOR NOTES - Narrative (Details) Details 66 false false R67.htm 9955546 - Disclosure - 2.25% CONVERTIBLE SENIOR NOTES - Capped call transactions (Details) Notes http://www.anipharmaceuticals.com/role/A225CONVERTIBLESENIORNOTESCappedcalltransactionsDetails 2.25% CONVERTIBLE SENIOR NOTES - Capped call transactions (Details) Details 67 false false R68.htm 9955547 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENT AND HEDGING ACTIVITY (Details) Sheet http://www.anipharmaceuticals.com/role/DERIVATIVEFINANCIALINSTRUMENTANDHEDGINGACTIVITYDetails DERIVATIVE FINANCIAL INSTRUMENT AND HEDGING ACTIVITY (Details) Details http://www.anipharmaceuticals.com/role/DERIVATIVEFINANCIALINSTRUMENTANDHEDGINGACTIVITY 68 false false R69.htm 9955548 - Disclosure - INVENTORIES - Schedule of inventory (Details) Sheet http://www.anipharmaceuticals.com/role/INVENTORIESScheduleofinventoryDetails INVENTORIES - Schedule of inventory (Details) Details 69 false false R70.htm 9955549 - Disclosure - INVENTORIES - Narrative (Details) Sheet http://www.anipharmaceuticals.com/role/INVENTORIESNarrativeDetails INVENTORIES - Narrative (Details) Details 70 false false R71.htm 9955550 - Disclosure - PROPERTY AND EQUIPMENT, NET - Schedule of property and equipment (Details) Sheet http://www.anipharmaceuticals.com/role/PROPERTYANDEQUIPMENTNETScheduleofpropertyandequipmentDetails PROPERTY AND EQUIPMENT, NET - Schedule of property and equipment (Details) Details 71 false false R72.htm 9955551 - Disclosure - PROPERTY AND EQUIPMENT, NET - Narrative (Details) Sheet http://www.anipharmaceuticals.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails PROPERTY AND EQUIPMENT, NET - Narrative (Details) Details 72 false false R73.htm 9955552 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) Sheet http://www.anipharmaceuticals.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) Details 73 false false R74.htm 9955553 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Components (Details) Sheet http://www.anipharmaceuticals.com/role/GOODWILLANDINTANGIBLEASSETSComponentsDetails GOODWILL AND INTANGIBLE ASSETS - Components (Details) Details 74 false false R75.htm 9955554 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Amortization (Details) Sheet http://www.anipharmaceuticals.com/role/GOODWILLANDINTANGIBLEASSETSAmortizationDetails GOODWILL AND INTANGIBLE ASSETS - Amortization (Details) Details 75 false false R76.htm 9955555 - Disclosure - FAIR VALUE - Narrative (Details) Sheet http://www.anipharmaceuticals.com/role/FAIRVALUENarrativeDetails FAIR VALUE - Narrative (Details) Details 76 false false R77.htm 9955556 - Disclosure - FAIR VALUE - CVR fair value level 3 (Details) Sheet http://www.anipharmaceuticals.com/role/FAIRVALUECVRfairvaluelevel3Details FAIR VALUE - CVR fair value level 3 (Details) Details 77 false false R78.htm 9955557 - Disclosure - FAIR VALUE - Level 3 (Details) Sheet http://www.anipharmaceuticals.com/role/FAIRVALUELevel3Details FAIR VALUE - Level 3 (Details) Details 78 false false R79.htm 9955558 - Disclosure - FAIR VALUE - Accrued licensor payments (Details) Sheet http://www.anipharmaceuticals.com/role/FAIRVALUEAccruedlicensorpaymentsDetails FAIR VALUE - Accrued licensor payments (Details) Details 79 false false R80.htm 9955559 - Disclosure - FAIR VALUE - Hierarchy (Details) Sheet http://www.anipharmaceuticals.com/role/FAIRVALUEHierarchyDetails FAIR VALUE - Hierarchy (Details) Details 80 false false R81.htm 9955560 - Disclosure - MEZZANINE AND STOCKHOLDERS' EQUITY (Details) Sheet http://www.anipharmaceuticals.com/role/MEZZANINEANDSTOCKHOLDERSEQUITYDetails MEZZANINE AND STOCKHOLDERS' EQUITY (Details) Details http://www.anipharmaceuticals.com/role/MEZZANINEANDSTOCKHOLDERSEQUITY 81 false false R82.htm 9955561 - Disclosure - EARNINGS (LOSS) PER SHARE - Schedule of diluted earnings per share (Details) Sheet http://www.anipharmaceuticals.com/role/EARNINGSLOSSPERSHAREScheduleofdilutedearningspershareDetails EARNINGS (LOSS) PER SHARE - Schedule of diluted earnings per share (Details) Details http://www.anipharmaceuticals.com/role/EARNINGSLOSSPERSHARETables 82 false false R83.htm 9955562 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) Sheet http://www.anipharmaceuticals.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails STOCK-BASED COMPENSATION - Narrative (Details) Details 83 false false R84.htm 9955563 - Disclosure - STOCK-BASED COMPENSATION - Expense (Details) Sheet http://www.anipharmaceuticals.com/role/STOCKBASEDCOMPENSATIONExpenseDetails STOCK-BASED COMPENSATION - Expense (Details) Details 84 false false R85.htm 9955564 - Disclosure - STOCK-BASED COMPENSATION - Fair value options (Details) Sheet http://www.anipharmaceuticals.com/role/STOCKBASEDCOMPENSATIONFairvalueoptionsDetails STOCK-BASED COMPENSATION - Fair value options (Details) Details 85 false false R86.htm 9955565 - Disclosure - STOCK-BASED COMPENSATION - Stock option activity (Details) Sheet http://www.anipharmaceuticals.com/role/STOCKBASEDCOMPENSATIONStockoptionactivityDetails STOCK-BASED COMPENSATION - Stock option activity (Details) Details 86 false false R87.htm 9955566 - Disclosure - STOCK-BASED COMPENSATION - RSA activity (Details) Sheet http://www.anipharmaceuticals.com/role/STOCKBASEDCOMPENSATIONRSAactivityDetails STOCK-BASED COMPENSATION - RSA activity (Details) Details 87 false false R88.htm 9955567 - Disclosure - STOCK-BASED COMPENSATION - RSU activity (Details) Sheet http://www.anipharmaceuticals.com/role/STOCKBASEDCOMPENSATIONRSUactivityDetails STOCK-BASED COMPENSATION - RSU activity (Details) Details 88 false false R89.htm 9955568 - Disclosure - STOCK-BASED COMPENSATION - Performance shares activity (Details) Sheet http://www.anipharmaceuticals.com/role/STOCKBASEDCOMPENSATIONPerformancesharesactivityDetails STOCK-BASED COMPENSATION - Performance shares activity (Details) Details 89 false false R90.htm 9955569 - Disclosure - INCOME TAXES - Narrative (Details) Sheet http://www.anipharmaceuticals.com/role/INCOMETAXESNarrativeDetails INCOME TAXES - Narrative (Details) Details 90 false false R91.htm 9955570 - Disclosure - INCOME TAXES - Income (Loss) Before Taxes (Details) Sheet http://www.anipharmaceuticals.com/role/INCOMETAXESIncomeLossBeforeTaxesDetails INCOME TAXES - Income (Loss) Before Taxes (Details) Details 91 false false R92.htm 9955571 - Disclosure - INCOME TAXES - Provision (Details) Sheet http://www.anipharmaceuticals.com/role/INCOMETAXESProvisionDetails INCOME TAXES - Provision (Details) Details 92 false false R93.htm 9955572 - Disclosure - INCOME TAXES - Effective rate (Details) Sheet http://www.anipharmaceuticals.com/role/INCOMETAXESEffectiverateDetails INCOME TAXES - Effective rate (Details) Details 93 false false R94.htm 9955573 - Disclosure - INCOME TAXES - Deferred tax (Details) Sheet http://www.anipharmaceuticals.com/role/INCOMETAXESDeferredtaxDetails INCOME TAXES - Deferred tax (Details) Details 94 false false R95.htm 9955574 - Disclosure - INCOME TAXES - Income Taxes Paid (Details) Sheet http://www.anipharmaceuticals.com/role/INCOMETAXESIncomeTaxesPaidDetails INCOME TAXES - Income Taxes Paid (Details) Details 95 false false R96.htm 9955575 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details) Sheet http://www.anipharmaceuticals.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails COMMITMENTS AND CONTINGENCIES - Narrative (Details) Details 96 false false R97.htm 9955576 - Disclosure - COMMITMENTS AND CONTINGENCIES - Leases expense (Details) Sheet http://www.anipharmaceuticals.com/role/COMMITMENTSANDCONTINGENCIESLeasesexpenseDetails COMMITMENTS AND CONTINGENCIES - Leases expense (Details) Details 97 false false R98.htm 9955577 - Disclosure - COMMITMENTS AND CONTINGENCIES - Operating Lease maturity (Details) Sheet http://www.anipharmaceuticals.com/role/COMMITMENTSANDCONTINGENCIESOperatingLeasematurityDetails COMMITMENTS AND CONTINGENCIES - Operating Lease maturity (Details) Details 98 false false R99.htm 9955578 - Disclosure - COMMITMENTS AND CONTINGENCIES - Finance Lease maturity (Details) Sheet http://www.anipharmaceuticals.com/role/COMMITMENTSANDCONTINGENCIESFinanceLeasematurityDetails COMMITMENTS AND CONTINGENCIES - Finance Lease maturity (Details) Details 99 false false R100.htm 9955579 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.anipharmaceuticals.com/role/RELATEDPARTYTRANSACTIONSDetails RELATED PARTY TRANSACTIONS (Details) Details http://www.anipharmaceuticals.com/role/RELATEDPARTYTRANSACTIONSTables 100 false false R101.htm 9955580 - Disclosure - RELATED PARTY TRANSACTIONS - Schedule of related parties (Details) Sheet http://www.anipharmaceuticals.com/role/RELATEDPARTYTRANSACTIONSScheduleofrelatedpartiesDetails RELATED PARTY TRANSACTIONS - Schedule of related parties (Details) Details 101 false false R102.htm 9955581 - Disclosure - SEGMENT REPORTING - Revenue (Details) Sheet http://www.anipharmaceuticals.com/role/SEGMENTREPORTINGRevenueDetails SEGMENT REPORTING - Revenue (Details) Details 102 false false R103.htm 9955582 - Disclosure - SEGMENT REPORTING - Geographic (Details) Sheet http://www.anipharmaceuticals.com/role/SEGMENTREPORTINGGeographicDetails SEGMENT REPORTING - Geographic (Details) Details 103 false false All Reports Book All Reports anip-20251231.htm anip-20251231.xsd anip-20251231_cal.xml anip-20251231_def.xml anip-20251231_lab.xml anip-20251231_pre.xml anip-20251231_g1.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/cyd/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true